Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials

被引：5
作者：
McBrien, Claire N. [1 ]
Menzies-Gow, Andrew [2 ]
机构：
[1] Imperial Coll London, London, England
[2] Royal Brompton Hosp, Resp Med, Sydney St, London SW3 6NP, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 53卷 / 05期
关键词：
INHALED CORTICOSTEROIDS; MULTICENTER; THERAPY; BURDEN;
D O I：
10.1183/13993003.00599-2019
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials
    Sven C. van Dijkman
    Arzu Yorgancıoğlu
    Ian Pavord
    Guy Brusselle
    Paulo M. Pitrez
    Sean Oosterholt
    Sourabh Fumali
    Anurita Majumdar
    Oscar Della Pasqua
    [J]. Advances in Therapy, 2024, 41 : 1201 - 1225
  • [32] Impact of a low-cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample
    Chatkin, JM
    Blanco, DC
    Scaglia, N
    Wagner, MB
    Fritscher, CC
    [J]. JOURNAL OF ASTHMA, 2006, 43 (04) : 263 - 266
  • [33] A multistakeholder Delphi consensus core outcome set for clinical trials in moderate-to-severe asthma (coreASTHMA)
    Tejwani, Vickram
    Chang, Hsing-Yuan
    Tran, Annie P.
    Al Naber, Jennifer
    Gutzwiller, Florian S.
    Winders, Tonya A.
    Khurana, Sandhya
    Sumino, Kaharu
    Mosnaim, Giselle
    Moloney, Rachael M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (01) : 116 - +
  • [34] Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational study
    Nelsen, Linda M.
    Cockle, Sarah M.
    Gunsoy, Necdet B.
    Jones, Paul
    Albers, Frank C.
    Bradford, Eric S.
    Mullerova, Hana
    [J]. JOURNAL OF ASTHMA, 2020, 57 (09) : 1006 - 1016
  • [35] Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment
    Tan, Jerry K. L.
    Balagurusamy, Madhan
    Fung, Karen
    Gupta, Aditya K.
    Thomas, D. Richard
    Sapra, Sheetal
    Lynde, Charles
    Poulin, Yves
    Gulliver, Wayne
    Sebaldt, Rolf J.
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 (04) : 204 - 208
  • [36] Anti-IL-5 therapy in patients with severe eosinophilic asthma - clinical efficacy and possible criteria for treatment response
    Drick, Nora
    Seeliger, Benjamin
    Welte, Tobias
    Fuge, Jan
    Suhling, Hendrik
    [J]. BMC PULMONARY MEDICINE, 2018, 18
  • [37] Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history
    Tabatabaian, Farnaz
    Ledford, Dennis K.
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2018, 11 : 53 - 61
  • [38] Clinical trial research in focus: do trials prepare us to deliver precision medicine in those with severe asthma?
    Brightling, Christopher E.
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (02) : 92 - 95
  • [39] Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype
    Al Efraij, Khalid
    FitzGerald, J. Mark
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (07) : 669 - 676
  • [40] Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials
    Xiong, Xiao-feng
    Zhu, Min
    Wu, Hong-xia
    Fan, Li-li
    Cheng, De-yun
    [J]. RESPIRATORY RESEARCH, 2019, 20 (1)
12345